(Q37640968)

English

Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

0 references

1 reference

Europe PubMed Central

Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

object named as

Sabino Iliceto

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Massimo Napodano

3

object named as

Massimo Napodano

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

author name string

Giuseppe Tarantini

1

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Renato Razzolini

2

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Claudio Bilato

4

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Angelo Ramondo

5

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

publication date

27 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

676-683

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Comparison of mortality rates in acute myocardial infarction treated by percutaneous coronary intervention versus fibrinolysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Is primary angioplasty for some as good as primary angioplasty for all?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance of time-to-treatment?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infa

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

The relation between treatment benefit and underlying risk in meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm--paradoxic or predictable?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Timing of ischemic onset estimated from the electrocardiogram is better than historical timing for predicting outcome after reperfusion therapy for acute anterior myocardial infarction: a DANish trial in Acute Myocardial Infarction 2 (DANAMI-2) subs

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Delay in presentation and reperfusion therapy in ST-elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Relation of total annual coronary angioplasty volume of physicians and hospitals on outcomes of primary angioplasty for acute myocardial infarction (data from the 1995 Coronary Angioplasty Reporting System of the New York State Department of Health)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Stenting versus thrombolysis in acute myocardial infarction trial (STAT)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP506

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHP506

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

release_bgejmurgrjf5bgy24ze2zlfemu

1 reference

https://api.fatcat.wiki/v0/release/bgejmurgrjf5bgy24ze2zlfemu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37640968&oldid=1844495015"